Literature DB >> 30269474

Alveolar Squamous Cell Metaplasia: Preneoplastic Lesion?

Adriana Handra-Luca1,2.   

Abstract

Entities:  

Year:  2018        PMID: 30269474      PMCID: PMC6250930          DOI: 10.4132/jptm.2018.09.07

Source DB:  PubMed          Journal:  J Pathol Transl Med        ISSN: 2383-7837


× No keyword cloud information.
To the Editor, We have read with great interest the report of Song et al. [1] on lung squamous cell carcinomas (SCC) developing in the context of usual interstitial pneumonia. Squamous dysplastic foci were detected at the tumor periphery. However, such lesions are rarely mentioned in the medical literature, possibly because most tumors are already at an advanced stage when resected. We would like to draw attention on microscopic lesions of the same morphological spectrum, those of squamous cell metaplasia (SCM) of the alveolar lining that we have recently identified in a zone of mild alveolar fibrosis on a lung resection specimen for a 2.3-cm large adenocarcinoma. The lesions consisted of several foci of nonkeratinizing SCM developing/in continuity with the unilayered alveolar lining (Fig. 1). When multicellular and pluristratified, the SCM lesions protruded in the underlying fibrous tissue of the alveolar wall. The zone of mild interstitial fibrosis with approximatively 10 SCM foci measured 2.5–3 mm and was detected in normal lung parencyma, at distance from the tumor. There were no well-defined honeycomb-type lesions in the resected lung. In the SCM foci, p63 was positive in basal and suprabasal cells and negative in superficial cells. There were no major cellular atypia, dyskeratosis, or keratin foci. Rare alveolar cells also showed nuclear p63 expression as well as several rounded buds (cystic or not), some reminiscent of thyroid solid cell nests. Thyroid transcription factor 1 and cytokeratin 5/6 (CK5/6) were positive throughout the whole thickness of SCM foci (Fig. 1). Pneumocyte bi-/multinucleation was also seen as well as lymphocytic foci, one of them at contact to a SCM focus.
Fig. 1.

(A) The lung parenchyma shows a zone of multiple (approximatively 10) p63-positive squamous cell metaplasia (SCM) foci (black arrows for SCM foci, white arrow for lymphocytic focus). (B) On the hematoxylin and eosin stained slide, the lesions consist in a multilayered epithelium composed of basal cuboidal cells, suprabasal cells and superficial spindle-appearing cells (black arrows). (C) The basal and suprabasal cells are immunoreactive for p63 while superficial cells are negative (black arrows for p63+ cells). (D) Thyroid transcription factor 1 is expressed by the cells throughout the entire thickness of the lesion, in both p63+ and p63– cells (black arrows for SCM foci, gray arrow for atypical pneumocyte nuclei). (E, F) A cystic cellular bud (reminiscent of thyroid solid cell nests) is detected in an alveolar septum (black arrows for the SCM bud, gray arrows for binucleated pneumocytes). (G) One of the SCM foci develop at close contact to the lymphocytic infiltrate (p63 immunohistochemistry, black arrow for the SCM focus, white arrow for the lymphcytic infiltrate). To note would be the presence of a binucleation with immunoreactivity to p63 in the SCM focus. (H) Cytokeratin 5/6 is expressed in spindle-appearing cells lining the alveoli and in the SCM foci (black arrows for cytokeratin 5/6+ cells).

Here, we report SCM of the alveolar unilayered epithelium. Multicellular, stratified SCM foci were detected on the hematoxilin and eosin stained slide while only paucicellular foci were detected on the immunohistochemistry slides for p63 or CK5/6. The precise origin of these lesions is difficult to identify, p63+CK5+ cells being reported in alveolar regeneration of chronic pulmonary fibrosis, diffuse alveolar damage, acute/usual interstitial pneumonia or influenza infection [2-6]. In the present case, the presence of lymphocytic foci may suggest a viral origin. However, given the fact that SCCs may also develop in the peripheral lung tissue, a putative preneoplastic potential can be proposed for alveolar SCM [7]. In conclusion, SCM may develop from the unilayered alveolar lining. The presence of several SCM foci may constitute a preneoplastic background for peripheral squamous cell carcinomas or squamous-type component in adenocarcinomas.
  6 in total

1.  RELATIONSHIP OF INTERSTITIAL PNEUMONIA HONEYCOMBING AND ATYPICAL EPITHELIAL PROLIFERATION TO CANCER OF THE LUNG.

Authors:  E C MEYER; A A LIEBOW
Journal:  Cancer       Date:  1965-03       Impact factor: 6.860

2.  Abnormal re-epithelialization and lung remodeling in idiopathic pulmonary fibrosis: the role of deltaN-p63.

Authors:  Marco Chilosi; Venerino Poletti; Bruno Murer; Maurizio Lestani; Alessandra Cancellieri; Licia Montagna; Paola Piccoli; Giulia Cangi; Gianpietro Semenzato; Claudio Doglioni
Journal:  Lab Invest       Date:  2002-10       Impact factor: 5.662

3.  Usual interstitial pneumonia with lung cancer: clinicopathological analysis of 43 cases.

Authors:  Dae Hyun Song; In Ho Choi; Sang Yun Ha; Kang Min Han; Jae Jun Lee; Min Eui Hong; Kyeongman Jeon; Man Pyo Chung; Jhingook Kim; Joungho Han
Journal:  Korean J Pathol       Date:  2014-02-25

4.  The changing anatomic position of squamous cell carcinoma of the lung - a new conundrum.

Authors:  William Krimsky; Nargiz Muganlinskaya; Saiyad Sarkar; Manasa Vulchi; Pujan Patel; Suman Rao; Joel Hammer; Ruth Evans; Muhammad Qureshi; Daniel Harley
Journal:  J Community Hosp Intern Med Perspect       Date:  2016-12-15

5.  p63(+)Krt5(+) distal airway stem cells are essential for lung regeneration.

Authors:  Wei Zuo; Ting Zhang; Daniel Zheng'An Wu; Shou Ping Guan; Audrey-Ann Liew; Yusuke Yamamoto; Xia Wang; Siew Joo Lim; Matthew Vincent; Mark Lessard; Christopher P Crum; Wa Xian; Frank McKeon
Journal:  Nature       Date:  2014-11-12       Impact factor: 49.962

6.  Incidence and predictive factors of lung cancer in patients with idiopathic pulmonary fibrosis.

Authors:  Eisuke Kato; Noboru Takayanagi; Yotaro Takaku; Naho Kagiyama; Tetsu Kanauchi; Takashi Ishiguro; Yutaka Sugita
Journal:  ERJ Open Res       Date:  2018-02-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.